日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial

帕尼单抗联合 5-氟尿嘧啶和亚叶酸钙或单独使用 5-氟尿嘧啶和亚叶酸钙作为 RAS 野生型转移性结直肠癌的维持治疗(PanaMa,AIO KRK 0212):一项随机、开放标签、II 期试验的最终疗效分析

Stahler, Arndt; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; Fischer von Weikersthal, Ludwig; Caca, Karel; Goekkurt, Eray; Ballhausen, Alexej; Sommerhäuser, Greta; Alig, Annabel H S; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja; Modest, Dominik P

Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanoma

西南肿瘤协作组 S0826:SCH 727965(NSC 727135,dinaciclib)治疗 IV 期黑色素瘤患者的 II 期临床试验

Lao, Christopher D; Moon, James; Ma, Vincent T; Fruehauf, John P; Flaherty, Lawrence E; Bury, Martin J; Martin, William G; Gross, Howard; Akerley, Wallace; Hopkins, Judith O; Patel, Sapna P; Sondak, Vernon K; Ribas, Antoni

Dermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial

在接受 FOLFOX + Pmab 诱导治疗后,RAS 野生型转移性结直肠癌患者接受氟尿嘧啶和亚叶酸钙联合或不联合帕尼单抗 (Pmab) 维持治疗后,皮肤病相关生活质量结局:PanaMa (AIO KRK 0212) II 期随机试验的预设次要分析

Ballhausen, A; Karthaus, M; Fruehauf, S; Graeven, U; Müller, L; König, A O; von Weikersthal, L F; Sommerhäuser, G; Jelas, I; Alig, A H S; Kurreck, A; Stahler, A; Goekkurt, E; Held, S; Kasper, S; Heinrich, K; Heinemann, V; Stintzing, S; Trarbach, T; Modest, D P

Diagnostic Yield and Clinical Implications of Implantable Loop Recorders in Patients with Syncope in Germany: A National Database Analysis

德国晕厥患者植入式循环记录仪的诊断率和临床意义:一项基于国家数据库的分析

Mueller-Leisse, Johanna; Hillmann, Henrike Aenne Katrin; Iserloh, Laura; Fruehauf, Bjoern; Duncker, David

Changes in survival of >3800 patients with metastatic colorectal cancer in Germany: results from a 16-year prospective longitudinal real-world data analysis

德国3800余例转移性结直肠癌患者生存率变化:一项为期16年的前瞻性纵向真实世界数据分析结果

Marschner, N; Seufferlein, T; Potthoff, K; Zahn, M-O; Uhlig, J; Dörfel, S; Karcher, A; Sauer, A; Maintz, C; Fruehauf, S; Hutzschenreuter, U; Tech, S; Grafetstätter, M; Kruggel, L; Jänicke, M

Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)

性别对帕尼单抗联合氟尿嘧啶和亚叶酸钙与单用氟尿嘧啶和亚叶酸钙作为 RAS 野生型转移性结直肠癌 (mCRC) 维持治疗的疗效和安全性的影响。PanaMa 研究 (AIO-KRK-0212) 的亚组分析

Heinrich, K; Karthaus, M; Fruehauf, S; Graeven, U; Mueller, L; König, A O; von Weikersthal, L Fischer; Caca, K; Kretzschmar, A; Goekkurt, E; Haas, S; Alig, A H S; Kurreck, A; Stahler, A; Held, S; Sommerhäuser, G; Heinemann, V; Stintzing, S; Trarbach, T; Modest, D P

Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212)

帕尼单抗联合氟尿嘧啶和亚叶酸与单用氟尿嘧啶和亚叶酸作为 RAS 野生型转移性结直肠癌维持治疗的比较:随机 PANAMA 试验 (AIO KRK 0212)

Modest, Dominik Paul; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; König, Alexander Otto; Fischer von Weikersthal, Ludwig; Caca, Karel; Kretzschmar, Albrecht; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Stahler, Arndt; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian; Trarbach, Tanja

Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer

FIRE-8 (AIO-KRK/YMO-0519) 试验研究方案:一项前瞻性、随机、开放标签、多中心 II 期临床试验,旨在研究三氟尿苷/替吡嘧啶联合帕尼单抗与三氟尿苷/替吡嘧啶联合贝伐单抗作为转移性结直肠癌患者一线治疗的疗效。

Sommerhäuser, G; Kurreck, A; Stintzing, S; Heinemann, V; von Weikersthal, L Fischer; Dechow, T; Kaiser, F; Karthaus, M; Schwaner, I; Fuchs, M; König, A; Roderburg, C; Hoyer, I; Quante, M; Kiani, A; Fruehauf, S; Müller, L; Reinacher-Schick, A; Ettrich, T J; Stahler, A; Modest, D P

A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer

多西他赛联合番茄红素治疗转移性去势抵抗性前列腺癌的II期研究

Zhuang, Eric; Uchio, Edward; Lilly, Michael; Zi, Xiaolin; Fruehauf, John P

BIOM-15. SUBVENTRICULAR ZONE INVOLVEMENT IS ASSOCIATED WITH WORSE OUTCOME IN GLIOMA WHO GRADE II INDEPENDENT OF MOLECULAR MARKERS

BIOM-15. 脑室下区受累与II级胶质瘤患者预后不良相关,且与分子标志物无关。

Randall, Leslie M; Monk, Bradley J; Moon, James; Parker, Ricardo; Al-Ghazi, Muthana; Wilczynski, Sharon; Fruehauf, John P; Markman, Maurie; Burger, Robert A; Karschnia, Philipp; Weller, Jonathan; Blobner, Jens; Stoecklein, Veit M; Dorostkar, Mario M; Rejeski, Kai D; Forbrig, Robert; Niyazi, Maximilian; von Baumgarten, Louisa; Dietrich, Jorg; Tonn, Joerg-Christian; Thon, Niklas